Pulmonary Function Testing Research 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.The Role of Continuous Glucose Monitoring in Detecting Early Dysglycemia and Clinical Outcomes in Patients with Cystic Fibrosis
Medicina (Kaunas). 2024 Mar 14;60(3):477. doi: 10.3390/medicina60030477.ABSTRACTCystic fibrosis-related diabetes (CFRD) is the most common comorbidity in patients with cystic fibrosis (CF). CFRD has been correlated with important clinical outcomes, including poor nutrition, reduced pulmonary function, and earlier mortality. However, clinical decline due to abnormalities of blood glucose (dysglycemia) begins early in CF, before the diagnosis of CFRD by the gold-standard oral glucose tolerance test (OGTT). Continuous glucose monitoring (CGM) has been validated in patients with CF and has been recognized as a valuable tool in...
Source: Medicina (Kaunas) - March 28, 2024 Category: Universities & Medical Training Authors: Lora Stanka Kirigin Bilo š Velimir Altabas Andrea Vuki ć Dugac Maja Bareti ć Source Type: research
The Role of Continuous Glucose Monitoring in Detecting Early Dysglycemia and Clinical Outcomes in Patients with Cystic Fibrosis
Medicina (Kaunas). 2024 Mar 14;60(3):477. doi: 10.3390/medicina60030477.ABSTRACTCystic fibrosis-related diabetes (CFRD) is the most common comorbidity in patients with cystic fibrosis (CF). CFRD has been correlated with important clinical outcomes, including poor nutrition, reduced pulmonary function, and earlier mortality. However, clinical decline due to abnormalities of blood glucose (dysglycemia) begins early in CF, before the diagnosis of CFRD by the gold-standard oral glucose tolerance test (OGTT). Continuous glucose monitoring (CGM) has been validated in patients with CF and has been recognized as a valuable tool in...
Source: Medicina (Kaunas) - March 28, 2024 Category: Universities & Medical Training Authors: Lora Stanka Kirigin Bilo š Velimir Altabas Andrea Vuki ć Dugac Maja Bareti ć Source Type: research
The Role of Continuous Glucose Monitoring in Detecting Early Dysglycemia and Clinical Outcomes in Patients with Cystic Fibrosis
Medicina (Kaunas). 2024 Mar 14;60(3):477. doi: 10.3390/medicina60030477.ABSTRACTCystic fibrosis-related diabetes (CFRD) is the most common comorbidity in patients with cystic fibrosis (CF). CFRD has been correlated with important clinical outcomes, including poor nutrition, reduced pulmonary function, and earlier mortality. However, clinical decline due to abnormalities of blood glucose (dysglycemia) begins early in CF, before the diagnosis of CFRD by the gold-standard oral glucose tolerance test (OGTT). Continuous glucose monitoring (CGM) has been validated in patients with CF and has been recognized as a valuable tool in...
Source: Medicina (Kaunas) - March 28, 2024 Category: Universities & Medical Training Authors: Lora Stanka Kirigin Bilo š Velimir Altabas Andrea Vuki ć Dugac Maja Bareti ć Source Type: research
The Role of Continuous Glucose Monitoring in Detecting Early Dysglycemia and Clinical Outcomes in Patients with Cystic Fibrosis
Medicina (Kaunas). 2024 Mar 14;60(3):477. doi: 10.3390/medicina60030477.ABSTRACTCystic fibrosis-related diabetes (CFRD) is the most common comorbidity in patients with cystic fibrosis (CF). CFRD has been correlated with important clinical outcomes, including poor nutrition, reduced pulmonary function, and earlier mortality. However, clinical decline due to abnormalities of blood glucose (dysglycemia) begins early in CF, before the diagnosis of CFRD by the gold-standard oral glucose tolerance test (OGTT). Continuous glucose monitoring (CGM) has been validated in patients with CF and has been recognized as a valuable tool in...
Source: Medicina (Kaunas) - March 28, 2024 Category: Universities & Medical Training Authors: Lora Stanka Kirigin Bilo š Velimir Altabas Andrea Vuki ć Dugac Maja Bareti ć Source Type: research
The Role of Continuous Glucose Monitoring in Detecting Early Dysglycemia and Clinical Outcomes in Patients with Cystic Fibrosis
Medicina (Kaunas). 2024 Mar 14;60(3):477. doi: 10.3390/medicina60030477.ABSTRACTCystic fibrosis-related diabetes (CFRD) is the most common comorbidity in patients with cystic fibrosis (CF). CFRD has been correlated with important clinical outcomes, including poor nutrition, reduced pulmonary function, and earlier mortality. However, clinical decline due to abnormalities of blood glucose (dysglycemia) begins early in CF, before the diagnosis of CFRD by the gold-standard oral glucose tolerance test (OGTT). Continuous glucose monitoring (CGM) has been validated in patients with CF and has been recognized as a valuable tool in...
Source: Medicina (Kaunas) - March 28, 2024 Category: Universities & Medical Training Authors: Lora Stanka Kirigin Bilo š Velimir Altabas Andrea Vuki ć Dugac Maja Bareti ć Source Type: research
The Role of Continuous Glucose Monitoring in Detecting Early Dysglycemia and Clinical Outcomes in Patients with Cystic Fibrosis
Medicina (Kaunas). 2024 Mar 14;60(3):477. doi: 10.3390/medicina60030477.ABSTRACTCystic fibrosis-related diabetes (CFRD) is the most common comorbidity in patients with cystic fibrosis (CF). CFRD has been correlated with important clinical outcomes, including poor nutrition, reduced pulmonary function, and earlier mortality. However, clinical decline due to abnormalities of blood glucose (dysglycemia) begins early in CF, before the diagnosis of CFRD by the gold-standard oral glucose tolerance test (OGTT). Continuous glucose monitoring (CGM) has been validated in patients with CF and has been recognized as a valuable tool in...
Source: Medicina (Kaunas) - March 28, 2024 Category: Universities & Medical Training Authors: Lora Stanka Kirigin Bilo š Velimir Altabas Andrea Vuki ć Dugac Maja Bareti ć Source Type: research
The Role of Continuous Glucose Monitoring in Detecting Early Dysglycemia and Clinical Outcomes in Patients with Cystic Fibrosis
Medicina (Kaunas). 2024 Mar 14;60(3):477. doi: 10.3390/medicina60030477.ABSTRACTCystic fibrosis-related diabetes (CFRD) is the most common comorbidity in patients with cystic fibrosis (CF). CFRD has been correlated with important clinical outcomes, including poor nutrition, reduced pulmonary function, and earlier mortality. However, clinical decline due to abnormalities of blood glucose (dysglycemia) begins early in CF, before the diagnosis of CFRD by the gold-standard oral glucose tolerance test (OGTT). Continuous glucose monitoring (CGM) has been validated in patients with CF and has been recognized as a valuable tool in...
Source: Medicina (Kaunas) - March 28, 2024 Category: Universities & Medical Training Authors: Lora Stanka Kirigin Bilo š Velimir Altabas Andrea Vuki ć Dugac Maja Bareti ć Source Type: research
The Role of Continuous Glucose Monitoring in Detecting Early Dysglycemia and Clinical Outcomes in Patients with Cystic Fibrosis
Medicina (Kaunas). 2024 Mar 14;60(3):477. doi: 10.3390/medicina60030477.ABSTRACTCystic fibrosis-related diabetes (CFRD) is the most common comorbidity in patients with cystic fibrosis (CF). CFRD has been correlated with important clinical outcomes, including poor nutrition, reduced pulmonary function, and earlier mortality. However, clinical decline due to abnormalities of blood glucose (dysglycemia) begins early in CF, before the diagnosis of CFRD by the gold-standard oral glucose tolerance test (OGTT). Continuous glucose monitoring (CGM) has been validated in patients with CF and has been recognized as a valuable tool in...
Source: Medicina (Kaunas) - March 28, 2024 Category: Universities & Medical Training Authors: Lora Stanka Kirigin Bilo š Velimir Altabas Andrea Vuki ć Dugac Maja Bareti ć Source Type: research
The Role of Continuous Glucose Monitoring in Detecting Early Dysglycemia and Clinical Outcomes in Patients with Cystic Fibrosis
Medicina (Kaunas). 2024 Mar 14;60(3):477. doi: 10.3390/medicina60030477.ABSTRACTCystic fibrosis-related diabetes (CFRD) is the most common comorbidity in patients with cystic fibrosis (CF). CFRD has been correlated with important clinical outcomes, including poor nutrition, reduced pulmonary function, and earlier mortality. However, clinical decline due to abnormalities of blood glucose (dysglycemia) begins early in CF, before the diagnosis of CFRD by the gold-standard oral glucose tolerance test (OGTT). Continuous glucose monitoring (CGM) has been validated in patients with CF and has been recognized as a valuable tool in...
Source: Medicina (Kaunas) - March 28, 2024 Category: Universities & Medical Training Authors: Lora Stanka Kirigin Bilo š Velimir Altabas Andrea Vuki ć Dugac Maja Bareti ć Source Type: research
The Role of Continuous Glucose Monitoring in Detecting Early Dysglycemia and Clinical Outcomes in Patients with Cystic Fibrosis
Medicina (Kaunas). 2024 Mar 14;60(3):477. doi: 10.3390/medicina60030477.ABSTRACTCystic fibrosis-related diabetes (CFRD) is the most common comorbidity in patients with cystic fibrosis (CF). CFRD has been correlated with important clinical outcomes, including poor nutrition, reduced pulmonary function, and earlier mortality. However, clinical decline due to abnormalities of blood glucose (dysglycemia) begins early in CF, before the diagnosis of CFRD by the gold-standard oral glucose tolerance test (OGTT). Continuous glucose monitoring (CGM) has been validated in patients with CF and has been recognized as a valuable tool in...
Source: Medicina (Kaunas) - March 28, 2024 Category: Universities & Medical Training Authors: Lora Stanka Kirigin Bilo š Velimir Altabas Andrea Vuki ć Dugac Maja Bareti ć Source Type: research
The Role of Continuous Glucose Monitoring in Detecting Early Dysglycemia and Clinical Outcomes in Patients with Cystic Fibrosis
Medicina (Kaunas). 2024 Mar 14;60(3):477. doi: 10.3390/medicina60030477.ABSTRACTCystic fibrosis-related diabetes (CFRD) is the most common comorbidity in patients with cystic fibrosis (CF). CFRD has been correlated with important clinical outcomes, including poor nutrition, reduced pulmonary function, and earlier mortality. However, clinical decline due to abnormalities of blood glucose (dysglycemia) begins early in CF, before the diagnosis of CFRD by the gold-standard oral glucose tolerance test (OGTT). Continuous glucose monitoring (CGM) has been validated in patients with CF and has been recognized as a valuable tool in...
Source: Medicina (Kaunas) - March 28, 2024 Category: Universities & Medical Training Authors: Lora Stanka Kirigin Bilo š Velimir Altabas Andrea Vuki ć Dugac Maja Bareti ć Source Type: research
The Role of Continuous Glucose Monitoring in Detecting Early Dysglycemia and Clinical Outcomes in Patients with Cystic Fibrosis
Medicina (Kaunas). 2024 Mar 14;60(3):477. doi: 10.3390/medicina60030477.ABSTRACTCystic fibrosis-related diabetes (CFRD) is the most common comorbidity in patients with cystic fibrosis (CF). CFRD has been correlated with important clinical outcomes, including poor nutrition, reduced pulmonary function, and earlier mortality. However, clinical decline due to abnormalities of blood glucose (dysglycemia) begins early in CF, before the diagnosis of CFRD by the gold-standard oral glucose tolerance test (OGTT). Continuous glucose monitoring (CGM) has been validated in patients with CF and has been recognized as a valuable tool in...
Source: Medicina (Kaunas) - March 28, 2024 Category: Universities & Medical Training Authors: Lora Stanka Kirigin Bilo š Velimir Altabas Andrea Vuki ć Dugac Maja Bareti ć Source Type: research
The Role of Continuous Glucose Monitoring in Detecting Early Dysglycemia and Clinical Outcomes in Patients with Cystic Fibrosis
Medicina (Kaunas). 2024 Mar 14;60(3):477. doi: 10.3390/medicina60030477.ABSTRACTCystic fibrosis-related diabetes (CFRD) is the most common comorbidity in patients with cystic fibrosis (CF). CFRD has been correlated with important clinical outcomes, including poor nutrition, reduced pulmonary function, and earlier mortality. However, clinical decline due to abnormalities of blood glucose (dysglycemia) begins early in CF, before the diagnosis of CFRD by the gold-standard oral glucose tolerance test (OGTT). Continuous glucose monitoring (CGM) has been validated in patients with CF and has been recognized as a valuable tool in...
Source: Medicina (Kaunas) - March 28, 2024 Category: Universities & Medical Training Authors: Lora Stanka Kirigin Bilo š Velimir Altabas Andrea Vuki ć Dugac Maja Bareti ć Source Type: research
The Role of Continuous Glucose Monitoring in Detecting Early Dysglycemia and Clinical Outcomes in Patients with Cystic Fibrosis
Medicina (Kaunas). 2024 Mar 14;60(3):477. doi: 10.3390/medicina60030477.ABSTRACTCystic fibrosis-related diabetes (CFRD) is the most common comorbidity in patients with cystic fibrosis (CF). CFRD has been correlated with important clinical outcomes, including poor nutrition, reduced pulmonary function, and earlier mortality. However, clinical decline due to abnormalities of blood glucose (dysglycemia) begins early in CF, before the diagnosis of CFRD by the gold-standard oral glucose tolerance test (OGTT). Continuous glucose monitoring (CGM) has been validated in patients with CF and has been recognized as a valuable tool in...
Source: Medicina (Kaunas) - March 28, 2024 Category: Universities & Medical Training Authors: Lora Stanka Kirigin Bilo š Velimir Altabas Andrea Vuki ć Dugac Maja Bareti ć Source Type: research
Long-term outcomes of survivors with influenza A H1N1 virus-induced severe pneumonia and ARDS: a single-center prospective cohort study
ConclusionThe improvements in pulmonary function and exercise capacity, imaging, and health-related quality of life had different time phase and impact on each other during 12 months of follow-up. Long-term outcomes of pulmonary fibrosis might be related to the lung injury and excessive lung fibroproliferation at the early stage during ICU admission. (Source: Frontiers in cellular and infection microbiology)
Source: Frontiers in cellular and infection microbiology - March 28, 2024 Category: Microbiology Source Type: research
